nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ABO blood group distributions in multiple sclerosis patients from Basque Country; O- as a protective factor
|
Lopetegi, Itziar |
|
|
|
4 |
|
artikel |
2 |
A case of autoimmune myositis after treatment with alemtuzumab for multiple sclerosis
|
Aouad, Patrick |
|
|
|
4 |
|
artikel |
3 |
Activity monitor use among persons with multiple sclerosis: Report on rate, pattern, and association with physical activity levels
|
Silveira, Stephanie L |
|
|
|
4 |
|
artikel |
4 |
A double-blind, placebo-controlled, single ascending-dose study of remyelinating antibody rHIgM22 in people with multiple sclerosis
|
Eisen, Andrew |
|
2017 |
|
4 |
|
artikel |
5 |
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder
|
Arru, Giannina |
|
2017 |
|
4 |
|
artikel |
6 |
A real-world comparison of relapse rates, healthcare costs and resource use among patients with multiple sclerosis newly initiating subcutaneous interferon beta-1a versus oral disease-modifying drugs
|
Bowen, James D |
|
|
|
4 |
|
artikel |
7 |
Assessing fatigue in multiple sclerosis: Psychometric properties of the five-item Modified Fatigue Impact Scale (MFIS-5)
|
Meca-Lallana, Virginia |
|
|
|
4 |
|
artikel |
8 |
Can a stress management programme reduce stress and improve quality of life in people diagnosed with multiple sclerosis?
|
Agland, Susan |
|
|
|
4 |
|
artikel |
9 |
Contactin-1 and contactin-2 in cerebrospinal fluid as potential biomarkers for axonal domain dysfunction in multiple sclerosis
|
Chatterjee, Madhurima |
|
|
|
4 |
|
artikel |
10 |
Corrigendum
|
|
|
|
|
4 |
|
artikel |
11 |
Does a modifiable risk factor score predict disability worsening in people with multiple sclerosis?
|
Marck, Claudia H |
|
|
|
4 |
|
artikel |
12 |
Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing–remitting multiple sclerosis in a real-world clinical setting: PROTEC
|
Berger, T |
|
|
|
4 |
|
artikel |
13 |
Environmental temperature and exercise modality independently impact central and muscle fatigue among people with multiple sclerosis
|
Grover, Geetika |
|
2017 |
|
4 |
|
artikel |
14 |
Evaluating the relationship between psychometric intelligence and cognitive functions in paediatric multiple sclerosis
|
Kapanci, Tugba |
|
|
|
4 |
|
artikel |
15 |
Factors associated with time from first-symptoms to diagnosis and treatment initiation of Multiple Sclerosis in Switzerland
|
Kaufmann, Marco |
|
|
|
4 |
|
artikel |
16 |
Glatiramer acetate as a clinically and cost-effective treatment of relapsing multiple sclerosis over 10 years of use within the National Health Service: Final results from the UK Risk Sharing Scheme
|
Giovannoni, G |
|
|
|
4 |
|
artikel |
17 |
Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis – a pilot trial
|
Storm-Larsen, C |
|
|
|
4 |
|
artikel |
18 |
HDL-cholesterol elevation associated with fingolimod and dimethyl fumarate therapies in multiple sclerosis
|
Blumenfeld Kan, S |
|
|
|
4 |
|
artikel |
19 |
High serum concentration of vitamin D may protect against multiple sclerosis
|
Biström, Martin |
|
|
|
4 |
|
artikel |
20 |
Identifying people with multiple sclerosis in the Canadian Primary Care Sentinel Surveillance Network
|
Marrie, Ruth Ann |
|
|
|
4 |
|
artikel |
21 |
Interferon beta-1b in treatment-naïve paediatric patients with relapsing–remitting multiple sclerosis: Two-year results from the BETAPAEDIC study
|
Gärtner, Jutta |
|
2017 |
|
4 |
|
artikel |
22 |
Is multiple sclerosis progression associated with the HLA-DR15 haplotype?
|
Stürner, Klarissa Hanja |
|
|
|
4 |
|
artikel |
23 |
Machine learning in secondary progressive multiple sclerosis: an improved predictive model for short-term disability progression
|
Law, Marco TK |
|
|
|
4 |
|
artikel |
24 |
Magnetic resonance spectroscopy evidence for declining gliosis in MS patients treated with ocrelizumab versus interferon beta-1a
|
MacMillan, Erin L |
|
|
|
4 |
|
artikel |
25 |
Monitoring cognitive change in multiple sclerosis using a computerized cognitive battery
|
De Meijer, L |
|
|
|
4 |
|
artikel |
26 |
PARP-1 deregulation in multiple sclerosis
|
Meira, Maria |
|
|
|
4 |
|
artikel |
27 |
Patient-reported outcomes in multiple sclerosis: Validation of the Quality of Life in Neurological Disorders (Neuro-QoL™) short forms
|
Medina, Luis D |
|
|
|
4 |
|
artikel |
28 |
Pregnancy and multiple sclerosis: Risk of unplanned pregnancy and drug exposure in utero
|
Smith, Andrew L |
|
|
|
4 |
|
artikel |
29 |
Prevalence of multiple sclerosis in Cuenca, Ecuador
|
Correa-Díaz, Edgar Patricio |
|
|
|
4 |
|
artikel |
30 |
Prevalence of neutralising antibodies to interferon-beta and clinical response in Chinese patients with relapsing multiple sclerosis
|
Lau, Alexander Y |
|
2017 |
|
4 |
|
artikel |
31 |
Randomized controlled trial of an e-learning designed behavioral intervention for increasing physical activity behavior in multiple sclerosis
|
Motl, Robert W |
|
2017 |
|
4 |
|
artikel |
32 |
Randomized, Placebo-controlled Crossover Study of Dalfampridine Extended-release in Transverse Myelitis
|
Schwartz, Kateryna |
|
2017 |
|
4 |
|
artikel |
33 |
Real-world experience of fingolimod in patients with multiple sclerosis (MS Fine): An observational study in the UK
|
Mazibrada, Gordon |
|
|
|
4 |
|
artikel |
34 |
Self-report sleep quality combined with sleep time variability distinguishes differences in fatigue, anxiety, and depression in individuals with multiple sclerosis: A secondary analysis
|
Siengsukon, Catherine F |
|
|
|
4 |
|
artikel |
35 |
Serum hepcidin levels in multiple sclerosis
|
Bsteh, Gabriel |
|
|
|
4 |
|
artikel |
36 |
Serum neurofilament light chain concentration in a phase 1/2 trial of autologous mesenchymal stem cell transplantation
|
Baldassari, Laura E |
|
|
|
4 |
|
artikel |
37 |
Serum Neurofilament Light Chain in NMOSD and Related Disorders: Comparison According to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies Status
|
S, Mariotto |
|
2017 |
|
4 |
|
artikel |
38 |
Serum neurofilament light levels correlate with change of olfactory function in multiple sclerosis
|
Bsteh, Gabriel |
|
|
|
4 |
|
artikel |
39 |
Subcutaneous interferon β-1a three times weekly and the natural evolution of gadolinium-enhancing lesions into chronic black holes in relapsing and progressive multiple sclerosis: Analysis of PRISMS and SPECTRIMS trials
|
Traboulsee, A |
|
2017 |
|
4 |
|
artikel |
40 |
Successful utilization of the EMR in a multiple sclerosis clinic to support quality improvement and research initiatives at the point of care
|
Claire Simon, Kelly |
|
|
|
4 |
|
artikel |
41 |
The efficacy of cladribine tablets in CIS patients retrospectively assigned the diagnosis of MS using modern criteria: Results from the ORACLE-MS study
|
Freedman, Mark S |
|
2017 |
|
4 |
|
artikel |
42 |
The neutrophil-to-lymphocyte ratio is associated with multiple sclerosis
|
Hasselbalch, IC |
|
|
|
4 |
|
artikel |
43 |
The topographical model of MS: Empirical evaluation of the recapitulation hypothesis
|
Laitman, Benjamin M |
|
|
|
4 |
|
artikel |
44 |
Thrombin generation correlates with disease duration in multiple sclerosis (MS): Novel insights into the MS-associated prothrombotic state
|
Parsons, Martin EM |
|
2017 |
|
4 |
|
artikel |
45 |
Updated diagnostic criteria for neuromyelitis optica spectrum disorder: Similar outcomes of previously separate cohorts
|
McCreary, M |
|
|
|
4 |
|
artikel |
46 |
Use of healthcare services by patients with multiple sclerosis in France over 2010–2015: a nationwide population-based study using health administrative data
|
Roux, J. |
|
|
|
4 |
|
artikel |
47 |
Validation of a consumer-grade activity monitor for continuous daily activity monitoring in individuals with multiple sclerosis
|
Block, Valerie J |
|
|
|
4 |
|
artikel |
48 |
Validation of the Brief International Cognitive Assessment for Multiple Sclerosis in Japan
|
Niino, Masaaki |
|
2017 |
|
4 |
|
artikel |